Short Interest in Molecular Partners AG (NASDAQ:MOLN) Increases By 76.1%

Molecular Partners AG (NASDAQ:MOLN – Get Rating) was the target of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 16,200 shares, an increase of 76.1% from the May 15th total of 9,200 shares. Based on an average daily volume of 25,900 shares, the […]

Related Keywords

,Morgan Stanley ,Molecular Partners Company Profile Get Rating ,Jpmorgan Chase Co ,Credit Suisse Group ,Kempen Co ,Hermes Inc ,Molecular Partners ,Get Rating ,Suisse Group ,Federated Hermes ,Partners Company Profile ,Nasdaq Moln ,Moln ,Medical ,Stocks ,Options ,Put ,Call ,